These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 10602422

  • 1. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
    Winter SS, Greene JM, McConnell TS, Willman CL.
    Leukemia; 1999 Dec; 13(12):2007-11. PubMed ID: 10602422
    [Abstract] [Full Text] [Related]

  • 2. BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML).
    Arana-Trejo RM, Ruíz Sánchez E, Ignacio-Ibarra G, Báez de la Fuente E, Garces O, Gómez Morales E, Castro Granados M, Ovilla Martínez R, Rubio-Borja ME, Solís Anaya L, Herrera P, Delgado Llamas J, Kofman S.
    Clin Lab Haematol; 2002 Jun; 24(3):145-50. PubMed ID: 12067277
    [Abstract] [Full Text] [Related]

  • 3. Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib.
    Agirre X, Román-Gómez J, Vázquez I, Jiménez-Velasco A, Larráyoz MJ, Lahortiga I, Andreu EJ, Márquez J, Beltrán de Heredia JM, Odero MD, Prósper F, Calasanz MJ.
    Cancer Genet Cytogenet; 2005 Jul 01; 160(1):22-6. PubMed ID: 15949566
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
    Suh SP, Kee SJ, Lim WH, Song JW, Lee SK, Kim JP, Shin JH, Ryang DW.
    Clin Chem Lab Med; 2000 Sep 01; 38(9):939-44. PubMed ID: 11097354
    [Abstract] [Full Text] [Related]

  • 6. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
    van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NC.
    Blood; 1996 Jun 15; 87(12):5213-7. PubMed ID: 8652835
    [Abstract] [Full Text] [Related]

  • 7. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
    Mundhada S, Luthra R, Cano P.
    BMC Cancer; 2004 Jun 17; 4():25. PubMed ID: 15202948
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis.
    Saglio G, Pane F, Gottardi E, Frigeri F, Buonaiuto MR, Guerrasio A, de Micheli D, Parziale A, Fornaci MN, Martinelli G, Salvatore F.
    Blood; 1996 Feb 01; 87(3):1075-80. PubMed ID: 8562932
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.
    Bennour A, Ouahchi I, Achour B, Zaier M, Youssef YB, Khelif A, Saad A, Sennana H.
    Med Oncol; 2013 Mar 01; 30(1):348. PubMed ID: 23269583
    [Abstract] [Full Text] [Related]

  • 11. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
    Li S, Ilaria RL, Million RP, Daley GQ, Van Etten RA.
    J Exp Med; 1999 May 03; 189(9):1399-412. PubMed ID: 10224280
    [Abstract] [Full Text] [Related]

  • 12. TaqMan RT-PCR assay coupled with capillary electrophoresis for quantification and identification of bcr-abl transcript type.
    Luthra R, Sanchez-Vega B, Medeiros LJ.
    Mod Pathol; 2004 Jan 03; 17(1):96-103. PubMed ID: 14657955
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction.
    Muddathir AM, Kordofani AA, Fadl-Elmula IM.
    Saudi Med J; 2013 Jan 03; 34(1):29-33. PubMed ID: 23299156
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation.
    Score J, Calasanz MJ, Ottman O, Pane F, Yeh RF, Sobrinho-Simões MA, Kreil S, Ward D, Hidalgo-Curtis C, Melo JV, Wiemels J, Nadel B, Cross NC, Grand FH.
    Leukemia; 2010 Oct 03; 24(10):1742-50. PubMed ID: 20703256
    [Abstract] [Full Text] [Related]

  • 19. BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran.
    Ayatollahi H, Keramati MR, Shirdel A, Kooshyar MM, Raiszadeh M, Shakeri S, Sadeghian MH.
    Caspian J Intern Med; 2018 Oct 03; 9(1):65-70. PubMed ID: 29387322
    [Abstract] [Full Text] [Related]

  • 20. The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
    Klco JM, Kreisel FH, Zehnbauer BA, Kulkarni S, Hassan A, Frater JL.
    Am J Hematol; 2008 Dec 03; 83(12):901-7. PubMed ID: 18932238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.